PACIRA BIOSCIENCES, INC. Debt Securities, Available-for-sale
PACIRA BIOSCIENCES, INC. (PCRX) had Debt Securities, Available-for-sale of $136.07 million as of 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2023-11-02
- 2023-09-30: Debt Securities, Available-for-sale $136.07M.
- 2023-06-30: Debt Securities, Available-for-sale $133.96M.
- 2023-03-31: Debt Securities, Available-for-sale $146.74M.
- 2022-12-31: Debt Securities, Available-for-sale $221.72M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2023-09-30 | $136.07M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $133.96M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $146.74M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $221.72M 10-Q · filed 2023-11-02 |
| 2022-09-30 | $236.69M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $194.33M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $225.44M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $70.83M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $559.82M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $540.82M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $558.34M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $517.16M 10-Q · filed 2021-11-03 |
| 2020-09-30 | $450.94M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $256.50M 10-Q · filed 2020-08-06 |
| 2019-12-31 | $278.52M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |